Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
Survey sought to assess the relative implicit biases of gynecologic healthcare providers regarding women with diagnoses of cervical vs ovarian cancer.
Ovarian Cancer
Ovarian Cancer News & Features
Imported Doxorubicin Similar to US FDA-Approved Brand in Relapsed/Refractory Ovarian Cancer
This retrospective analysis determined the effect of Doxil vs Lipodox brands of doxorubicin, used for the treatment of recurrent or refractory ovarian cancer.
Low-Dose Aspirin May Lower Ovarian Cancer Risk
Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk.
Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.
Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer
Researchers conducted a retrospective analysis to determine the impact of inflammatory responses in patients with ovarian cancer undergoing first-line chemotherapy with or without bevacizumab.
Ovarian Cancer Clinical Trials
Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy
Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Want to read more?
Please login or register first to view this content.
Next post in Ovarian Cancer
